AMWL vs GILD · rev $106.9M vs P/E 18, rev $7.80B
American Well Corp (AMWL) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
American Well Corp (AMWL) is a health information services company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported AMWL revenue for 2026-06-30 was $106.9M. Net income was -$20.8M. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. AMWL currently screens at market cap $132.8M.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
AMWL currently screens at market cap $132.8M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the AMWL and GILD stock pages for the full models.
Not investment advice.